HomeTARA • NASDAQ
Protara Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.76M | 19.71% |
Net income | -13.26M | -18.17% |
Net profit margin | — | — |
Earnings per share | -0.31 | 38.00% |
EBITDA | -14.67M | -19.81% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 132.67M | 62.79% |
Total assets | 144.64M | 53.72% |
Total liabilities | 12.35M | 0.37% |
Total equity | 132.29M | — |
Shares outstanding | 38.59M | — |
Price to book | 1.97 | — |
Return on assets | -24.47% | — |
Return on capital | -25.96% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -13.26M | -18.17% |
Cash from operations | -12.45M | -47.64% |
Cash from investing | -6.51M | 77.86% |
Cash from financing | 13.00K | — |
Net change in cash | -18.95M | 49.91% |
Free cash flow | -8.07M | -71.64% |
Previous close
$6.75
Day range
$6.01 - $6.40
Year range
$2.28 - $10.48
Market cap
242.33M USD
Avg Volume
477.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Website
Employees
31
